Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Westera

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The International Journal of Applied Radiation and Isotopes|November 1, 1981
The synthesis of some 11C-labelled antiepileptic drugs with potential utility as radiopharmaceuticals: hydantoins and barbituratesD Roeda, G Westera
International Journal of Nuclear Medicine and Biology|January 1, 1982
Labeled bleomycin as a tumor localizing agent III. Selectivity of tumor tissue uptake of the different forms of [57Co] bleomycin A2 and B2C M Vos, G Westera
European Journal of Nuclear Medicine|January 1, 1982
Labelled bleomycin as a tumour-localizing agent. II. The effect of dose loading of the different forms of 57Cobalt-bleomycin A2, B2, and pepleomycin on the tissue distribution and tumour uptake in tumour-bearing ratsC M Vos, G Westera
European Heart Journal|August 1, 1985
Myocardial uptake of radioactively labelled free fatty acidsG Westera, F C Visser
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Uptake of a monoclonal antibody against CEA (Tumak 431/31) in a human colon tumor (Co-112) xenografted in the nude mouse. Dependence on tumor size and injected doseS Duewell, W Horst, G Westera
The International Journal of Applied Radiation and Isotopes|April 1, 1985
A convenient method for the preparation of 99mTc(V)dimercaptosuccinic acid (99mTc(V)-DMSA)G Westera, A Gadze, W Horst
Journal of Inorganic Biochemistry|June 1, 1982
Different iron(II) complexes of bleomycin A2C M Vos, G Westera, D Schipper
Cancer Immunology, Immunotherapy : CII|December 1, 1994
Differences in biodistribution of the anti-(carcinoembryonic antigen) murine monoclonal antibody CE-25, its F(ab')2 fragment and its intact mainly human chimeric form CE 4-8-13. Dependence on tumour size and amount of antibody injectedG Westera, T Rülicke, A Smith, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|August 24, 1993
[Positron-emission tomography (PET)--basic considerations]G K von Schulthess, G Westera, P A Schubiger
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Modeling alternatives for cerebral carbon-11-iomazenil kineticsA Buck, G Westera, G K vonSchulthess, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The International Journal of Applied Radiation and Isotopes|November 1, 1981
The synthesis of some 11C-labelled antiepileptic drugs with potential utility as radiopharmaceuticals: hydantoins and barbituratesD Roeda, G Westera
International Journal of Nuclear Medicine and Biology|January 1, 1982
Labeled bleomycin as a tumor localizing agent III. Selectivity of tumor tissue uptake of the different forms of [57Co] bleomycin A2 and B2C M Vos, G Westera
European Journal of Nuclear Medicine|January 1, 1982
Labelled bleomycin as a tumour-localizing agent. II. The effect of dose loading of the different forms of 57Cobalt-bleomycin A2, B2, and pepleomycin on the tissue distribution and tumour uptake in tumour-bearing ratsC M Vos, G Westera
European Heart Journal|August 1, 1985
Myocardial uptake of radioactively labelled free fatty acidsG Westera, F C Visser
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Uptake of a monoclonal antibody against CEA (Tumak 431/31) in a human colon tumor (Co-112) xenografted in the nude mouse. Dependence on tumor size and injected doseS Duewell, W Horst, G Westera
The International Journal of Applied Radiation and Isotopes|April 1, 1985
A convenient method for the preparation of 99mTc(V)dimercaptosuccinic acid (99mTc(V)-DMSA)G Westera, A Gadze, W Horst
Journal of Inorganic Biochemistry|June 1, 1982
Different iron(II) complexes of bleomycin A2C M Vos, G Westera, D Schipper
Cancer Immunology, Immunotherapy : CII|December 1, 1994
Differences in biodistribution of the anti-(carcinoembryonic antigen) murine monoclonal antibody CE-25, its F(ab')2 fragment and its intact mainly human chimeric form CE 4-8-13. Dependence on tumour size and amount of antibody injectedG Westera, T Rülicke, A Smith, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|August 24, 1993
[Positron-emission tomography (PET)--basic considerations]G K von Schulthess, G Westera, P A Schubiger
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Modeling alternatives for cerebral carbon-11-iomazenil kineticsA Buck, G Westera, G K vonSchulthess, et al.
Pageof 6